COVID-19 vaccine delivery and distribution statement from MD Anderson
The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration’s decision on Friday, Dec. 11, to grant Emergency Use Authorization. At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for use with frontline health care workers, which is scheduled for delivery on...
Novel antibody-drug conjugate shows promising early results in rare blood cancer
ABSTRACT 167
A phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center found IMGN632, a novel CD123...